Su, J., Ma, Q., Long, W., Tang, H., Wu, C., Luo, M., . . . Liu, Q. (2019). LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas. Front Oncol.
Stile di citazione ChicagoSu, Jun, et al. "LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas." Front Oncol 2019.
Citazione MLASu, Jun, et al. "LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas." Front Oncol 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.